J9282 Mitomycin intravesical inst
Also known as: intravesical mitomycin, bladder mitomycin
Injection of mitomycin for intravesical instillation. Direct bladder administration for urothelial cancer treatment and prevention.
In Plain Language
bladder cancer treatment; cancer prevention injection
Clinical Context
Used for non-muscle-invasive bladder cancer as adjuvant or maintenance therapy. Reduces recurrence rates when used after transurethral resection.
RVU Information
CPT J9282 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9282?
CPT J9282 (Mitomycin intravesical inst) is a J Codes (Drugs) code. Injection of mitomycin for intravesical instillation. Direct bladder administration for urothelial cancer treatment and prevention.
How is J9282 administered?
CPT J9282 is administered by a healthcare provider, typically via injection or infusion. Used for non-muscle-invasive bladder cancer as adjuvant or maintenance therapy. Reduces recurrence rates when used after transurethral resection. It is used by Urology, Oncology, Surgery.
When is CPT J9282 used?
Used for non-muscle-invasive bladder cancer as adjuvant or maintenance therapy. Reduces recurrence rates when used after transurethral resection.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.